EUVIMEDEUVIMED entdecken
Open Access

Long-term outcomes of severe rheumatic mitral stenosis after undergoing percutaneous mitral commissurotomy and mitral valve replacement: A 10-year experience

Wasinee Promratpan iD, Nonthikorn Theerasuwipakorn iD, Vorarit Lertsuwunseri iD, Suphot Srimahachota

Journal of Cardiovascular and Thoracic Research · 30.06.2022 · 14 (2) · 101-107

DOI: 10.34172/jcvtr.2022.16 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cardiovascular and Thoracic Research, online erschienen am 12.06.2022. Verfasst von Wasinee Promratpan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Cardiac Center, King Chulalongkorn Memori…. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Percutaneous mitral commissurotomy (PTMC) and mitral valve replacement (MVR) are treatments of choice for severe rheumatic mitral stenosis (MS). Data regarding the long-term outcomes of patients who underwent PTMC and MVR are limited.

Methods

A retrospective cohort study was conducted to evaluate the long-term outcomes of patients with severe rheumatic MS who underwent PTMC or MVR between 2010 to 2020. The primary outcome comprised of all-cause death, stroke or systemic embolism, heart failure hospitalization and re-intervention. Cox regression was used to investigate predictors of the primary outcome.

Results

264 patients were included in analysis, 164 patients (62.1%) in PTMC group and 100 patients in MVR group (37.9%). The majority were females (80.7%) and had atrial fibrillation (68.6%). The mean age was 49.52 (SD: 13.03) years old. MVR group had more age and AF, higher Wilkins’ score with smaller MVA. Primary outcome occurred significantly higher in PTMC group (37.2% vs 22%, P=0.002), as well as, re-intervention (18.3% vs 0%, P 50 mmHg (HR 2.99; 95%CI 1.01, 8.84; P=0.047) were the only predictors of primary outcome.

Conclusion

Primary outcome occurred in PTMC group more than MVR group which was driven by re-intervention. However, all-cause mortality, stroke or systemic embolism and heart failure hospitalization were not significantly different.

Schlagwörter

Stichwörter der Autor:innen

Long-Term OutcomeMitral Valve ReplacementPercutaneous Mitral CommissurotomyRheumatic Mitral Stenosis

Autor:innen und Institutionen

  • Division of Cardiovascular Medicine, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Cardiac Center, King Chulalongkorn Memorial Hospital, 10330, Bangkok, Thailand.

ORCID-Profile: Wasinee Promratpan, Nonthikorn Theerasuwipakorn, Vorarit Lertsuwunseri

Zitieren

APA

Promratpan, W., Theerasuwipakorn, N., Lertsuwunseri, V., & Srimahachota, S. (2022). Long-term outcomes of severe rheumatic mitral stenosis after undergoing percutaneous mitral commissurotomy and mitral valve replacement: A 10-year experience. Journal of Cardiovascular and Thoracic Research, 14(2), 101-107. https://doi.org/10.34172/jcvtr.2022.16

Vancouver

Promratpan W, Theerasuwipakorn N, Lertsuwunseri V, Srimahachota S. Long-term outcomes of severe rheumatic mitral stenosis after undergoing percutaneous mitral commissurotomy and mitral valve replacement: A 10-year experience. Journal of Cardiovascular and Thoracic Research. 2022;14(2):101-107. doi:10.34172/jcvtr.2022.16

BibTeX
@article{Promratpan2022,
  author = {Promratpan, Wasinee and Theerasuwipakorn, Nonthikorn and Lertsuwunseri, Vorarit and Srimahachota, Suphot},
  title = {Long-term outcomes of severe rheumatic mitral stenosis after undergoing percutaneous mitral commissurotomy and mitral valve replacement: A 10-year experience},
  journal = {Journal of Cardiovascular and Thoracic Research},
  year = {2022},
  volume = {14},
  number = {2},
  pages = {101--107},
  doi = {10.34172/jcvtr.2022.16}
}
Kostenlos starten →